The National Institutes of Health will fund a large, randomized, placebo‑controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19.
News & Blog
GET TO KNOW US!
AllAllergyAsthmaBest PracticesCase StudiesClinical ResearchCNS/NeurologyConsortiaCriterium NewsData ManagementDermatologyEDCFDAGastroenterologyGlobal Clinical ResearchHematologyIndustry NewsInfectious DiseaseIVR-IWR IxRSMedical DevicesMen's HealthMetabolic SyndromeOncologyOphthalmologyOrphan DiseasesOutsourcingPain ManagementPharmaceutical DevelopmentPress ReleasesPublic InterestTranslational ResearchTrial TechnologyUrologyWomen's Health
Intranasal administration of OMV-Spike protected against challenge with SARS-CoV-2 has significant advantages over injectables
The past year has seen the rapid global spread of SARS-CoV-2—the virus responsible for the ongoing COVID-19 pandemic. While non-pharmaceutical interventions have been the mainstay of epidemic control to date, vaccination is likely to constitute the definitive, long-term defence strategy against SARS-CoV-2 morbidity, mortality, and transmission, offering the best hope of a return to normal life.
Criterium, Inc. Marks 30th Anniversary of Delivering Exceptional Personal Attention and Services for All Clinical Trial Elements
Criterium, Inc. a full-service contract research organization (CRO) dedicated to providing efficiency and expertise in Clinical Trial Services to pharmaceuticals, biotech, and medical device companies throughout the world, celebrates its 30th anniversary.
Criterium's Academic Breast Cancer Consortium (ABRCC) is comprised of 15 renowned academic and community sites in North America, conducting translational research in Breast Cancer studies for major pharmaceutical companies who are working on the most current clinical trials for advanced treatments of breast cancer. While 2020 was a year dominated by COVID-19 news and tragedy, breast cancer research and breakthroughs can't wait for COVID to "go away" – and research in this area continues on full-speed. Our ABRCC researchers reflect on 2020 and look ahead to 2021 with renewed hope.
For November's Lung Cancer Awareness Month, Heather Smith and Melissa Turner share the stories of their cancer journeys. The women took very different routes to the CU Cancer Center and the world-renowned lung cancer care of Ross Camidge, MD. On this episode of the CU Anschutz 360 podcast, learn why they love everything about Dr. Camidge’s practice, especially the fact that he makes them laugh.
- FDA Approves StrataGraft for the Treatment of Adults with Thermal Burns
- The Trial Master File 10 Essentials for Success
- Large clinical trial to study repurposed drugs to treat COVID-19 symptoms
- Positive Preclinical Data for SARS-CoV-2 Nose Spray Vaccine
- Tracking COVID-19 Vaccine Development Efforts Across the Globe